Statera Biopharma, Inc. Debt Conversion, Converted Instrument, Amount
Statera Biopharma, Inc. reported Debt Conversion, Converted Instrument, Amount of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-10-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2022-10-06
- Statera Biopharma, Inc. debt conversion, converted instrument, amount for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Statera Biopharma, Inc. debt conversion, converted instrument, amount for fiscal 2020 was $3.44M.
| Period end | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-10-06 |
| 2020-12-31 | $3.44M 10-K · filed 2022-10-06 |